Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.
Bacillus subtilis spores are being used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders in both humans and animals. Since B. subtilis is an aerobic saprophyte, how spores may benefit the gut microbiota is an intriguing question, since other probiotics such as Lactobaci...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2000
|
| _version_ | 1797099388118499328 |
|---|---|
| author | Hoa, N Baccigalupi, L Huxham, A Smertenko, A Van, P Ammendola, S Ricca, E Cutting, A |
| author_facet | Hoa, N Baccigalupi, L Huxham, A Smertenko, A Van, P Ammendola, S Ricca, E Cutting, A |
| author_sort | Hoa, N |
| collection | OXFORD |
| description | Bacillus subtilis spores are being used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders in both humans and animals. Since B. subtilis is an aerobic saprophyte, how spores may benefit the gut microbiota is an intriguing question, since other probiotics such as Lactobacillus spp. which colonize the gut are anerobes. As a first step in understanding the potential effects of ingesting spores, we have characterized five commercial products. An extensive biochemical, physiological, and phylogenetic analysis has revealed that four of these products are mislabeled. Moreover, four of these products showed high levels of antibiotic resistance. |
| first_indexed | 2024-03-07T05:22:58Z |
| format | Journal article |
| id | oxford-uuid:df9022ff-52f7-4a3e-8067-94248065ad5e |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:22:58Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:df9022ff-52f7-4a3e-8067-94248065ad5e2022-03-27T09:40:14ZCharacterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:df9022ff-52f7-4a3e-8067-94248065ad5eEnglishSymplectic Elements at Oxford2000Hoa, NBaccigalupi, LHuxham, ASmertenko, AVan, PAmmendola, SRicca, ECutting, ABacillus subtilis spores are being used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders in both humans and animals. Since B. subtilis is an aerobic saprophyte, how spores may benefit the gut microbiota is an intriguing question, since other probiotics such as Lactobacillus spp. which colonize the gut are anerobes. As a first step in understanding the potential effects of ingesting spores, we have characterized five commercial products. An extensive biochemical, physiological, and phylogenetic analysis has revealed that four of these products are mislabeled. Moreover, four of these products showed high levels of antibiotic resistance. |
| spellingShingle | Hoa, N Baccigalupi, L Huxham, A Smertenko, A Van, P Ammendola, S Ricca, E Cutting, A Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title | Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title_full | Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title_fullStr | Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title_full_unstemmed | Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title_short | Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. |
| title_sort | characterization of bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders |
| work_keys_str_mv | AT hoan characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT baccigalupil characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT huxhama characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT smertenkoa characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT vanp characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT ammendolas characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT riccae characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders AT cuttinga characterizationofbacillusspeciesusedfororalbacteriotherapyandbacterioprophylaxisofgastrointestinaldisorders |